Nimbus Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Nimbus Therapeutics?

Nimbus Therapeutics has 18 investors including Biotechnology Value Fund And RA Capital Management.

Q: How much funding has Nimbus Therapeutics raised to date?

Nimbus Therapeutics has raised obfuscated.

Overview

Nimbus Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Nimbus Therapeutics

CB Rank

9073

Nimbus Therapeutics uses computational technology to create selective small molecule therapeutics.

Acquired by

Gilead Sciences

Founded

obfuscation

Private

Private Equity

Boston, Massachusetts, United States

51-100

nimbustx.com

Biotechnology

Health Care

Medical Device

Therapeutics

Funding Rounds

Private Equity

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Bruce Booth: Co-Founder
Past Role: Caxton Associates, Principal
Ramy Farid: Co-Founder and Director
Past Role: Rutgers University, Assistant Professor of Chemistry

Details

Sub-Organization of

Gilead Sciences

Legal Name

Nimbus Therapeutics, Inc.

Also Known As

Nimbus Discovery

Operating Status

Active

Company Type

For Profit

Founders

Bruce Booth

About the Company

Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical-stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical

development. Nimbus Therapeutics designs highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer, and immune-inflammatory disorders.

Phone Number

(857) 999-2009

Contact Email

info@nimbustx.com

Predictions & Insights

Growth Insight

See this Growth Insight

Nimbus Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

NDI-219216 (WRN Inhibitor)

An investigational non-covalent inhibitor targeting Werner syndrome helicase (WRN) for treatment of microsatellite instability-high (MSI-H) tumors.

NDI-219216 (WRN Inhibitor)

A non-covalent small molecule inhibitor targeting Werner syndrome helicase (WRN) for treatment of microsatellite instability-high (MSI-H) tumors.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Nimbus Therapeutics	10	obfuscated obfuscation	Atlas Venture, Google Ventures, SR One	Private Equity
obfuscated obfuscation	Private Equity Round - Nimbus Therapeutics	10	obfuscated obfuscation	Atlas Venture, Google Ventures, SR One	Private Equity
obfuscated obfuscation	Private Equity Round - Nimbus Therapeutics	10	obfuscated obfuscation	Atlas Venture, Google Ventures, SR One	Private Equity
obfuscated obfuscation	Private Equity Round - Nimbus Therapeutics	10	obfuscated obfuscation	Atlas Venture, Google Ventures, SR One	Private Equity
obfuscated obfuscation	Private Equity Round - Nimbus Therapeutics	10	obfuscated obfuscation	Atlas Venture, Google Ventures, SR One	Private Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Nimbus Therapeutics	10	obfuscated obfuscation	Atlas Venture, Google Ventures, SR One	Private Equity
obfuscated obfuscation	Private Equity Round - Nimbus Therapeutics	10	obfuscated obfuscation	Atlas Venture, Google Ventures, SR One	Private Equity
obfuscated obfuscation	Private Equity Round - Nimbus Therapeutics	10	obfuscated obfuscation	Atlas Venture, Google Ventures, SR One	Private Equity
obfuscated obfuscation	Private Equity Round - Nimbus Therapeutics	10	obfuscated obfuscation	Atlas Venture, Google Ventures, SR One	Private Equity
obfuscated obfuscation	Private Equity Round - Nimbus Therapeutics	10	obfuscated obfuscation	Atlas Venture, Google Ventures, SR One	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Biotechnology Value Fund	—	Private Equity Round - Nimbus Therapeutics	—
Biotechnology Value Fund	—	Private Equity Round - Nimbus Therapeutics	—
Biotechnology Value Fund	—	Private Equity Round - Nimbus Therapeutics	—
Biotechnology Value Fund	—	Private Equity Round - Nimbus Therapeutics	—
Biotechnology Value Fund	—	Private Equity Round - Nimbus Therapeutics	—